KalVista Pharmaceuticals (KALV) Stock Chart & Stock Price History $10.87 -0.53 (-4.65%) Closing price 03/3/2025 04:00 PM EasternExtended Trading$11.37 +0.50 (+4.60%) As of 03/3/2025 06:21 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends KalVista Pharmaceuticals Stock Price Performance 5 Day Performance-0.11%1 Month Performance+17.90%3 Month Performance+11.72%6 Month Performance-12.13%Year-To-Date Performance+28.34%1 Year Performance-23.13% Receive KALV Stock News and Ratings via EmailSign-up to receive the latest news and ratings for KalVista Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address KALV Stock Chart for Tuesday, March, 4, 2025 KALV Chart by TradingView KalVista Pharmaceuticals Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization03/03/2025$11.40$10.87-4.65%$11.75$10.711.06 million shs$537.17 million02/28/2025$10.69$11.40+6.64%$11.40$10.48809,457 shs$563.37 million02/27/2025$10.88$10.69-1.76%$11.02$10.57502,439 shs$528.28 million02/26/2025$10.77$10.88+1.04%$11.39$10.43780,453 shs$537.77 million02/25/2025$10.35$10.77+4.06%$10.85$10.141.05 million shs$532.23 million02/24/2025$10.03$10.35+3.19%$10.54$9.94671,535 shs$511.48 million02/21/2025$10.64$10.03-5.73%$10.85$9.98447,802 shs$495.68 million02/20/2025$10.71$10.64-0.65%$10.83$10.50335,563 shs$525.83 million02/19/2025$9.76$10.71+9.77%$11.00$9.64515,932 shs$529.29 million02/18/2025$9.76$9.76-0.03%$10.11$9.63283,338 shs$482.19 million Get the Latest News and Ratings for KALV and Related StocksEnter your email address below to receive the latest news and analysts' ratings for KalVista Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 02/17/2025$9.76$9.76$9.93$9.39198,408 shs$482.34 million02/14/2025$9.53$9.76+2.41%$9.93$9.39198,408 shs$482.34 million02/13/2025$9.33$9.53+2.14%$9.55$8.99275,996 shs$470.97 million02/12/2025$9.27$9.33+0.65%$9.47$9.01528,462 shs$461.09 million02/11/2025$9.19$9.27+0.87%$9.30$8.96239,790 shs$458.12 million02/10/2025$9.20$9.19-0.11%$9.29$8.84310,081 shs$454.15 million02/07/2025$9.62$9.20-4.37%$9.68$9.15303,808 shs$454.66 million02/06/2025$9.90$9.62-2.83%$10.02$9.58179,702 shs$475.42 million02/05/2025$9.75$9.90+1.54%$10.03$9.65355,204 shs$489.26 million02/04/2025$9.22$9.75+5.75%$9.94$9.39457,485 shs$481.85 million02/03/2025$8.91$9.22+3.48%$9.43$8.74362,712 shs$455.65 million Related Companies CGON Stock Price Chart AGIO Stock Price Chart HRMY Stock Price Chart IDYA Stock Price Chart BLTE Stock Price Chart JANX Stock Price Chart GLPG Stock Price Chart TARS Stock Price Chart VERA Stock Price Chart AAPG Stock Price Chart Receive KALV Stock News and Ratings via EmailSign-up to receive the latest news and ratings for KalVista Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:KALV) was last updated on 3/4/2025 by MarketBeat.com Staff From Our PartnersHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredLeaked Trump video exposes his secret stocksTen investments secretly owned by Trump’s biggest backers. Ten investments intrinsically tied to the polici...Porter & Company | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredElon Social Security shock?“A Maniacal Sense of Urgency” We could be just days away from Elon Musk launching his next big venture. One...Altimetry | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredTrump’s Victory Could Spark Major Gains for Gold – Don’t Miss Out This "Patriot's Tax Shield" lets you defend your wealth with real, solid gold. Our exclusive, free wealth pr...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding KalVista Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share KalVista Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
